Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5'-Hydroxyasperentin is a secondary metabolite of the isocoumarin class, primarily produced by various fungal species such as Aspergillus flavus, Aspergillus tamarii, and Cladosporium cladosporioides. It is a hydroxylated derivative of asperentin, which is also known as cladosporin. Asperentin and its analogs are recognized for their potent biological activities, particularly as antifungal and antimalarial agents. They exert these effects by acting as highly selective inhibitors of the enzyme lysyl-tRNA synthetase (KRS), which is essential for protein synthesis; cladosporin is noted for its ability to inhibit Plasmodium falciparum KRS while showing minimal activity against the human version of the enzyme. The specific term "Production of 5'-hydroxyasperentin" refers to a biosynthetic process or an experimental measurement of the metabolite's synthesis rather than a defined therapeutic target molecule in humans.
Inhibition of lysyl-tRNA synthetase (KRS)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5'-Hydroxyasperentin.